Home › Idiopathic Pulmonary Fibrosis › North Carolina › Charlotte
Idiopathic Pulmonary Fibrosis clinical trials in Charlotte, NC
4 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
RecruitingPhase 3
- American Health Research - Charlotte Location, Charlotte
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
RecruitingPhase 3
- Clinical Research of Gastonia (CRG), Gastonia · 20 mi away
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 3
- Clinical Research of Rock Hill, Rock Hill · 23 mi away
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Clinical Research of Rock Hill, Rock Hill · 23 mi away
Idiopathic Pulmonary Fibrosis trials in other cities
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- New York City, NY7 studies
- Los Angeles, CA6 studies
- Chicago, IL6 studies
- Kansas City, KS6 studies
- Durham, NC6 studies
- Aurora, CO6 studies
- Winston-Salem, NC5 studies
- Nashville, TN5 studies
- Houston, TX5 studies
- El Paso, TX5 studies
Other studies in Charlotte
- Cancer (all types)29 studies
- Breast Cancer22 studies
- Non-Small Cell Lung Cancer22 studies
- Multiple Myeloma21 studies
- Acute Myeloid Leukemia18 studies
- Ovarian Cancer16 studies
- Obesity16 studies
- Colorectal Cancer15 studies
- Overweight15 studies
- Metastatic Cancer12 studies
- Heart Failure12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.